Pro-inflammatory phospholipid arachidonic acid/eicosapentaenoic acid ratio of dysmetabolic severely obese women

Obesity Surgery

Volumn 22, Issue 6, 2012, Pages 935-944

  Caspar Bauguil, S ^a,b   Fioroni, A ^b   Galinier, A ^a,b   Allenbach, S ^a   Pujol, M C ^a   Salvayre, R ^a   Cartier, A ^c   Lemieux, I ^c   Richard, D ^d   Biron, S ^d   Marceau, P ^d   Casteilla, L ^b   Penicaud L ^b,e   Mauriege P ^d  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c LAVAL UNIVERSITY   (Canada)

^d UNIVERSITÉ LAVAL   (Canada)

^e CENTRE DES SCIENCES DU GOÛT ET DE L ALIMENTATION   (France)

Author keywords

Adipokines; Fatty acids; Metabolic syndrome; Severe obesity

Indexed keywords

ADIPONECTIN; ARACHIDONIC ACID; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; MESSENGER RNA; PHOSPHOLIPID; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GAS CHROMATOGRAPHY; HUMAN; LIPID COMPOSITION; METABOLIC DISORDER; OBESITY; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ARACHIDONIC ACIDS; CHROMATOGRAPHY, GAS; EICOSAPENTAENOIC ACID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-6; METABOLIC SYNDROME X; OBESITY, MORBID; REAL-TIME POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT, ABDOMINAL;

EID: 84862616885     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-012-0633-0     Document Type: Article

References (38)

1. Liese AD, Mayer-Davis EJ, Haffner SM. Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev. 1998;20:157-72.
2. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444:881-7.
3. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444:875-80.
4. Fulop T, Tessier D, Carpentier A. The metabolic syndrome. Pathol Biol (Paris). 2006;54:375-86.
5. Bays HE. "Sick fat", metabolic disease, and atherosclerosis. Am J Med. 2009;122:S26-37.
6. Fischer-Posovszky P, Wabitsch M, Hochberg Z. Endocrinology of adipose tissue-an update. Horm Metab Res. 2007;39:314321.
7. Antuna-Puente B, Fève B, Fellahi S, et al. Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab. 2008;34:2-11.
8. Wajchenberg BL, Giannella-Neto D, da Silva MER, et al. Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Horm Metab Res. 2002;34:616621.
9. Aguilera CM, Gil-Campos M, Cañete R, et al. Alterations in plasma and tissue lipids associated with obesity and metabolic syndrome. Clin Sci (Lond). 2008;114:183-93.
10. Warensjö E, Risérus U, Vessby B. Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men. Diabetologia. 2005;48:1999-2005.
11. Schoen RE, Evans RW, Sankey SS, et al. Does visceral adipose tissue differ from subcutaneous adipose tissue in fatty acid content? Int J Obes Relat Metab Dis. 1996;20:346-52.
12. Raclot T, Langin D, Lafontan M, et al. Selective release of human fatty acids according to molecular structure. Biochem J. 1997;324:911-5.
13. Garaulet M, Pérez-Llalmas F, Pérez-Ayala M, et al. Site-specific differences in the fatty acid composition of abdominal adipose tissue in an obese population from a Mediterranean area: relation with dietary fatty acids, plasma lipid profile, serum insulin, and central obesity. Am J Clin Nutr. 2001;74:585-91.
14. Garaulet M, Hernandez-Morante JJ, Lujan J, et al. Relationship between fat cell size and number and fatty acid composition in adipose tissue from different fat depots in overweight/obese humans. Int J Obes. 2006;30:899-905.
15. Harris WS, Assaad B, Poston WC. Tissue omega-6/omega-3 fatty acid ratio and risk for coronary artery disease. Am J Cardiol. 2006;98:19i-26i.
16. DeClercq V, Taylor C, Zahradka P. Adipose tissue: the link between obesity and cardiovascular disease. Cardiovasc Hematol Disord Drug Targets. 2008;8:228-37.
17. Hodson L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res. 2008;47:348-80.
18. Field CJ, Angel A, Clandinin MT. Relationship of diet to the fatty acid composition of human adipose tissue structural and stored lipids. Am J Clin Nutr. 1985;42:1206-20.
19. Fernández-Quintela A, Churruca I, Portillo MP. The role of dietary fat in adipose tissue metabolism. Public Health Nutr. 2007;10:1126-31.
20. Jaworski K, Ahmadian M, Duncan RE, et al. AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency. Nat Med. 2009;15:159-68.
21. Fernández-Real JM, Broch M, Vendrell J, et al. Insulin resistance, inflammation and serum fatty acid composition. Diabetes Care. 2003;26:1362-8.
22. Garaulet M, Hernandez-Morante JJ, Tebar FJ, et al. Relation between degree of obesity and site-specific adipose tissue fatty acid composition in a Mediterranean population. Nutrition. 2011;27:170-6.
23. Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med. 2008;233:674-88.
24. Itoh M, Suganami T, Satoh N, et al. Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. Arterioscler Thromb Vasc Biol. 2007;27:1918-25.
25. Drevon CA. Fatty acids and expression of adipokines. Biochim Biophys Acta. 2005;1740:287-92.
26. Marceau P, Hould F-S, Potvin M, et al. Biliopancreatic diversion (duodenal switch procedure). Eur J Gastroenterol Hepatol. 1999;11:99-103.
27. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
28. World Health Organization (WHO). Part 1: diagnosis and classification of diabetes mellitus. Report of a WHO consultation 1999;1-59.
29. Drapeau V, Lemieux I, Richard D, et al. Waist circumference is useless to assess the prevalence of metabolic abnormalities in severely obese women. Obes Surg. 2007;17:905-9.
30. Drapeau V, Lemieux I, Richard D, et al.Metabolic profile in severely obese women is less deteriorated than expected when compared to moderately obese women. Obes Surg. 2006;16:501-9.
31. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
32. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocr Metab. 2000;85:2402-10.
33. Cartier A, Côté M, Lemieux I, et al. Sex differences in inflammatory markers: what is the contribution of visceral adiposity? Am J Clin Nutr. 2009;89:1307-14.
34. Côté M, Mauriège P, Bergeron J, et al. Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. J Clin Endocr Metab. 2005;90:1434-9.
35. Mauriège P, Marette A, Atgié C, et al. Regional variation in adipose tissue metabolism of severely obese women. J Lipid Res. 1995;36:672-84.
36. Mauriège P, Lacaille M, Gélinas Y, et al. Regional variation in adipose tissue secretory function among morbidly obese premenopausal women. Int J Obes 2008;32: Abstract S58.
37. Hernandez-Morante JJ, Milgaro FI, Larque E, et al. Relationship among adiponectin, adiponectin gene expression and fatty acid composition in morbidly obese patients. Obes Surg. 2007;17:516-24.
38. Fain JN, Madan AK, Hiler ML, et al. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology. 2004;145:2273-82.